346,745 people in Mongolia at least partially vaccinated against COVID-19

2021-04-04 13:15:00

Ulaanbaatar /MONTSAME/. Today’s COVID-19 daily briefing by the Ministry of Health reported that a total of 346,745 people in Mongolia or 17.8 percent of nationwide vaccination target, have been fully and partially vaccinated against COIVD-19. 

The vaccination continued on April 3 at 46 locations Ulaanbaatar city and Darkhan-Uul, Dornogobi, Tuv, Orkhon, Umnugobi and Gobi-Altai aimags, with over 900 healthcare workers of 128 vaccination teams administering vaccines to over 10,000 people. 

On April 4 and 5, more than 1,000 healthcare officers and doctors are working at 64 vaccination sites to vaccinate people aged over 50, reports the National Center for Communicable Diseases (NCOD). 

“There are around 245,000 people aged over 50 in Ulaanbaatar city and half of them or around 124,000 people have received the first dose of vaccines to date. After the vaccination for the remaining people aged over 50, people of other age groups will start getting the first dose of COVID-19 vaccines,” said O.Dashpagma, Director of the Vaccination Department of NCOD during the press briefing. 

Yesterday, April 3, Prime Minister L.Oyun-Erdene visited the vaccination sites in Ulaanbaatar city to get acquainted with the vaccine rollout process. During the visit, the Prime Minister assured that the period of partial restrictions ongoing between April 3 and 18 will allow to vaccinate up to 30,000 people a day, instead of daily average of 12,000. 

As a result of accelerating the vaccine rollout, around 2 million adult population of Mongolia are expected to receive the first dose of COVID-19 vaccines before June 1, and all target population in Ulaanbaatar city will be fully vaccinated within the month of May. 

Currently Mongolia has received a total of 809,740 doses of COVID-19 vaccines, including 164,000 doses of AstraZeneca via Indian assistance and COVAX Facility, 600,000 doses of Sinopharm (Verocell) vaccine from China and through procurement, and 20,000 doses of Sputnik-V vaccine purchased from Russia and 25,740 doses of Pfizer-BioNTech vaccine via COVAX Facility.